Dipeptidyl Peptidase IV Inhibitor MK-0626 Attenuates Pancreatic Islet Injury in Tacrolimus-Induced Diabetic Rats
Tacrolimus (TAC)-induced pancreatic islet injury is one of the important causes of new onset of diabetes in transplant recipients. This study was performed to evaluate whether a dipeptidyl peptidase (DPP) IV inhibitor is effective in improving TAC-induced diabetes mellitus by reducing pancreatic isl...
Main Authors: | Sun Woo Lim, Jin Long, Doh Kyoung Chan, Jin Jian, Piao Shang Guo, Chung Byung Ha, Yang Chul Woo |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Society of Nephrology
2014-06-01
|
Series: | Kidney Research and Clinical Practice |
Online Access: | http://www.sciencedirect.com/science/article/pii/S221191321400059X |
Similar Items
-
Dipeptidyl peptidase IV inhibitor MK-0626 attenuates pancreatic islet injury in tacrolimus-induced diabetic rats.
by: Long Jin, et al.
Published: (2014-01-01) -
Effects of Dipeptidyl Peptidase-4 Inhibition with MK-0431 on Syngeneic Mouse Islet Transplantation
by: Jyuhn-Huarng Juang, et al.
Published: (2014-01-01) -
Dipeptidyl peptidase IV (DDP IV) in NASH patients
by: Yasemin H. Balaban, et al.
Published: (2007-10-01) -
Tackling dipeptidyl peptidase IV in neurological disorders
by: Ghaith Al-Badri, et al.
Published: (2018-01-01) -
Dipeptidyl peptidase IV and its implication in cancer
by: Yarini M Arrebola, et al.